FDA Drug · D-0058-2023

Octreotide Acetate Injection 500 mcg/mL, 10 x 1 mL Single-Dose Unit-of-Use Syringes, For Subcutaneous or Intravenous Use, Rx Only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26505 U.S.A., Made in Italy, NDC: 67457-246-00 (syringe), 67457-246-01 (carton).

Class I · Terminated

Presence of Particulate Matter: Product complaint for the presence of glass particles in a syringe.

Affected lots / codes — check yours against thisLot #: AJ21002, Exp. 03/2024

Recalling firm: Viatris Inc, Canonsburg, PA
Classification: Class I (most serious — risk of serious harm)
Status: Terminated
Quantity: 22400 syringes
Distribution: Nationwide in the USA
Recall initiated: October 7, 2022
Classified: November 8, 2022
Terminated: January 12, 2024
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0058-2023%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →